Precipio Inc./$PRPO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Precipio Inc.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. It focuses on improving cancer diagnostics, particularly hematologic malignancies. Its objective is to enhance diagnostic accuracy and accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, and Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division and the Products Division.
Ticker
$PRPO
Sector
Primary listing
Employees
66
Headquarters
Website
Precipio Inc. Metrics
BasicAdvanced
$53m
-
-$0.23
1.20
-
Price and volume
Market cap
$53m
Beta
1.2
52-week high
$32.40
52-week low
$5.74
Average daily volume
34k
Financial strength
Current ratio
1.61
Quick ratio
1.235
Long term debt to equity
20.63
Total debt to equity
25.088
Interest coverage (TTM)
-16.47%
Profitability
EBITDA (TTM)
0.231
Gross margin (TTM)
44.52%
Net profit margin (TTM)
-1.51%
Operating margin (TTM)
-5.00%
Revenue per employee (TTM)
$360,000
Management effectiveness
Return on assets (TTM)
-3.92%
Return on equity (TTM)
-2.72%
Valuation
Price to revenue (TTM)
1.989
Price to book
3.64
Price to tangible book (TTM)
14.57
Price to free cash flow (TTM)
133.236
Free cash flow yield (TTM)
0.75%
Free cash flow per share (TTM)
0.224
Growth
Revenue change (TTM)
29.77%
Earnings per share change (TTM)
-92.27%
3-year revenue growth (CAGR)
36.71%
10-year revenue growth (CAGR)
32.16%
3-year earnings per share growth (CAGR)
-72.37%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Precipio Inc. stock?
Precipio Inc. (PRPO) has a market cap of $53M as of April 30, 2026.
What is the P/E ratio for Precipio Inc. stock?
The price to earnings (P/E) ratio for Precipio Inc. (PRPO) stock is 0 as of April 30, 2026.
Does Precipio Inc. stock pay dividends?
No, Precipio Inc. (PRPO) stock does not pay dividends to its shareholders as of April 30, 2026.
When is the next Precipio Inc. dividend payment date?
Precipio Inc. (PRPO) stock does not pay dividends to its shareholders.
What is the beta indicator for Precipio Inc.?
Precipio Inc. (PRPO) has a beta rating of 1.2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.